NEW YORK (GenomeWeb) — Interleukin today reported a 38 percent year-over year drop in its revenues, with genetic testing service revenues down 36 percent.

The firm said that for the three months ended Dec. 31, 2016, total revenues fell to $227,861 from $365,648 in Q4 2014. Genetic testing service revenues for the recently completed quarter was $150,993, compared to $234,369. Other revenues declined 41 percent in Q4 2016 to $76,868 from $131,279.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.